Location plays role in access to diabetic eye disease trials

FORT LAUDERDALE, Fla. — Patients who live in rural areas of the United States have to travel farther to participate in diabetic eye disease clinical trials, according to a study presented at the Retina World Congress.
Yoshihiro Yonekawa, MD, said that eye disease related to diabetes is a growing concern, but clinical trial sites are clustered in areas with higher populations.
“Diabetes is everywhere, but clinical trial sites are not,” he said. “Are there therefore geographic access disparities where some people have easier access to clinical trials while others don’t?

Full Story →